About This Journal
The Mental Health Clinician (MHC) is a peer-reviewed, bimonthly, clinical practice journal indexed in PubMed and PubMed Central (PMC). The MHC delves into new topics with each issue to provide psychiatric and neurologic pharmacists’... Read More
Appropriate use of single-dose injectable aripiprazole lauroxil in the treatment of schizophrenia
Involuntary medication treatment of schizophrenia in the inpatient setting
Clinical experience and treatment considerations with vesicular monoamine transport 2 inhibitors
Clinical pearls for the management of duloxetine patients with medical comorbidities
Suicide risk identification and mitigation in patients with chronic pain prescribed opioid medication
Features & Information
With $238 billion being spent on mental health each year and the growing shortage of psychiatrists, clinical pharmacists will continue to play an essential role on mental health teams. Discover the benefits of having a psychiatric pharmacist as part of the team in collaboration with the health care team, patients and caregivers by downloading these informative resources.
AAPP’s psychotropic LAI training programs are designed to expand patient access to these medications by reducing barriers and increasing pharmacist comfort with administration services. A multitude of helpful resources are available to equip pharmacists with the tools necessary to lead, innovate, and advance LAI patient care and clinic management.
The demand for psychiatric services to treat psychiatric and neurological disorders has dramatically increased. Psychiatric pharmacists can help meet this demand by working with a physician as part of a collaborative team to improve medication-related outcomes for patients with psychiatric or neurological disorders.